Tin tức & Cập nhật
Xem bài viết Dược
Xem
Chỉ hiển thị Multimedia

Methotrexate–leflunomide combo safe in rheumatoid arthritis
15 Oct 2021
Methotrexate (MTX) plus leflunomide (LEF) demonstrates a relatively good safety profile overall compared with the combination of MTX and sulfasalazine (SSZ) and strategies involving advanced therapies in rheumatoid arthritis (RA), reports a study.
15 Oct 2021

Baricitinib: A potential treatment for alopecia areata?
14 Oct 2021
bởiRoshini Claire Anthony
Baricitinib, an oral, selective Janus kinase (JAK)1/JAK2 inhibitor, may help improve hair growth in patients with severe alopecia areata, according to results from the phase III BRAVE-AA1 and BRAVE-AA2 trials.
14 Oct 2021

Second bDMARD after failure of non-TNFi biologic in RA shows modest drug survival, response
14 Oct 2021
A recent study has shown modest drug survival and primary response of a second biologic disease-modifying antirheumatic drug (bDMARD) in patients with rheumatoid arthritis (RA) switching due to failure of a nontumour necrosis factor inhibitor (non-TNFi) bDMARD as the first agent.
14 Oct 2021






